10 April 2025
On June 4, 2025, in Boston, Dr. Bin Wu, Founder and CEO of Cytodigm, will present “Exploring Treatment Engineering Approaches to Overcome Off-Target Toxicity” at the 4th In Vivo Cell Engineering & Gene Editing Summit.
In his talk, Dr. Wu will share Cytodigm’s latest advancements in the application of Cytofinity™ LNPs for in vivo cell engineering and gene editing.
Key points of discussion will include:
- Analyzing the antibody approach to targeting, along with the immunogenicity and toxicity associated with antibody conjugation.
- Exploring alternative strategies to enhance targeting and improve safety profiles without relying on antibody conjugation.
- Presenting Cytodigm’s innovative methods for targeting extrahepatic tissues and cells while minimizing off-target toxicity.
